Edgestream Partners L.P. Buys New Shares in Henry Schein, Inc. (NASDAQ:HSIC)

Edgestream Partners L.P. bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 22,119 shares of the company’s stock, valued at approximately $1,418,000.

Other hedge funds have also bought and sold shares of the company. Swedbank AB bought a new position in shares of Henry Schein during the 1st quarter valued at about $215,998,000. Norges Bank bought a new position in shares of Henry Schein during the 4th quarter valued at about $111,715,000. Thompson Siegel & Walmsley LLC bought a new position in shares of Henry Schein during the 2nd quarter valued at about $46,683,000. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 28.5% during the 1st quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock valued at $132,552,000 after purchasing an additional 388,843 shares during the last quarter. Finally, Fiduciary Management Inc. WI boosted its holdings in shares of Henry Schein by 17.1% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after purchasing an additional 333,855 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on HSIC. UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. JPMorgan Chase & Co. dropped their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Robert W. Baird decreased their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Finally, Barrington Research restated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Friday. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $77.10.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Henry Schein stock opened at $71.15 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The firm has a market capitalization of $9.11 billion, a P/E ratio of 24.04, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86. The company’s 50-day moving average is $69.89 and its 200 day moving average is $70.38.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same period in the prior year, the company posted $1.31 EPS. The firm’s revenue for the quarter was up .0% on a year-over-year basis. Research analysts forecast that Henry Schein, Inc. will post 4.75 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.